Sumoylation of Smad4, the Common Smad Mediator of Transforming Growth Factor-β Family Signaling*

Transforming growth factor-β (TGF-β) and TGF-β-related factors regulate cell growth, differentiation, and apoptosis, and play key roles in normal development and tumorigenesis. TGF-β family-induced changes in gene expression are mediated by serine/threonine kinase receptors at the cell surface and Smads as intracellular effectors. Receptor-activated Smads combine with a common Smad4 to translocate into the nucleus where they cooperate with other transcription factors to activate or repress transcription. The activities of the receptor-activated Smads are controlled by post-translational modifications such as phosphorylation and ubiquitylation. Here we show that Smad4 is modified by sumoylation. Sumoylation of Smad4 was enhanced by the conjugating enzyme Ubc9 and members of the PIAS family of SUMO ligases. A major sumoylation site in Smad4 was localized to Lys-159 in its linker segment with an additional site at Lys-113 in the MH-1 domain. Increased sumoylation in the presence of the PIASy E3 ligase correlated with targeting of Smad4 to subnuclear speckles that contain SUMO-1 and PIASy. Replacement of lysines 159 and 113 by arginines or increased sumoylation enhanced the stability of Smad4, and transcription in mammalian cells and Xenopus embryos. These observations suggest a role for Smad4 sumoylation in the regulation of TGF-β signaling through Smads.

[1]  F. Melchior,et al.  Activation of Transforming Growth Factor-β Signaling by SUMO-1 Modification of Tumor Suppressor Smad4/DPC4* , 2003, Journal of Biological Chemistry.

[2]  J. Iñiguez-Lluhí,et al.  A Synergy Control Motif within the Attenuator Domain of CCAAT/Enhancer-binding Protein α Inhibits Transcriptional Synergy through Its PIASy-enhanced Modification by SUMO-1 or SUMO-3* , 2003, The Journal of Biological Chemistry.

[3]  H. Yasuda,et al.  PIAS1 and PIASxα Function as SUMO-E3 Ligases toward Androgen Receptor and Repress Androgen Receptor-dependent Transcription* , 2002, The Journal of Biological Chemistry.

[4]  Peter F. Johnson,et al.  Transcriptional Activity of CCAAT/Enhancer-binding Proteins Is Controlled by a Conserved Inhibitory Domain That Is a Target for Sumoylation* , 2002, The Journal of Biological Chemistry.

[5]  F. Melchior,et al.  Transcription factor Sp3 is silenced through SUMO modification by PIAS1 , 2002, The EMBO journal.

[6]  L. Zon,et al.  SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. , 2002, Molecular cell.

[7]  O. Jänne,et al.  PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases , 2002, Molecular and Cellular Biology.

[8]  S. K. Zaidi,et al.  Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Miska,et al.  The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase , 2002, The EMBO journal.

[10]  Jeffrey L. Wrana,et al.  Signal Transduction by the TGF-β Superfamily , 2002, Science.

[11]  A. Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.

[12]  M. Goumans,et al.  Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors , 2002, The EMBO journal.

[13]  J. Markus,et al.  Covalent Attachment of the SUMO-1 Protein to the Negative Regulatory Domain of the c-Myb Transcription Factor Modifies Its Stability and Transactivation Capacity* , 2002, The Journal of Biological Chemistry.

[14]  T. Ouyang,et al.  SMIF, a Smad4-interacting protein that functions as a co-activator in TGFβ signalling , 2002, Nature Cell Biology.

[15]  Christopher D. Lima,et al.  Structural Basis for E2-Mediated SUMO Conjugation Revealed by a Complex between Ubiquitin-Conjugating Enzyme Ubc9 and RanGAP1 , 2002, Cell.

[16]  A. Brivanlou,et al.  Signal Transduction and the Control of Gene Expression , 2002, Science.

[17]  A. Dejean,et al.  The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity , 2002, Cell.

[18]  C. Heldin,et al.  Smad regulation in TGF-beta signal transduction. , 2001, Journal of cell science.

[19]  P. Jackson.  A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. , 2001, Genes & development.

[20]  L. Bruhn,et al.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. , 2001, Genes & development.

[21]  C. Hill,et al.  Loss of Smad4 Function in Pancreatic Tumors , 2001, The Journal of Biological Chemistry.

[22]  C. Mayhew,et al.  Regulation of Heat Shock Transcription Factor 1 by Stress-induced SUMO-1 Modification* , 2001, The Journal of Biological Chemistry.

[23]  M. Hochstrasser.  SP-RING for SUMO New Functions Bloom for a Ubiquitin-like Protein , 2001, Cell.

[24]  Allan Balmain,et al.  TGF-β signaling in tumor suppression and cancer progression , 2001, Nature Genetics.

[25]  L. Attisano,et al.  Cross-talk between the p42/p44 MAP Kinase and Smad Pathways in Transforming Growth Factor β1-induced Furin Gene Transactivation* , 2001, The Journal of Biological Chemistry.

[26]  T Misteli,et al.  Functional architecture in the cell nucleus. , 2001, The Biochemical journal.

[27]  R. Hay,et al.  Protein modification by SUMO. , 2001, Trends in biochemical sciences.

[28]  Serhiy Souchelnytskyi,et al.  Regulation of Smad signaling by protein kinase C , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  R. Derynck,et al.  Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Palvimo,et al.  Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Derynck,et al.  Structural and Functional Characterization of the Transforming Growth Factor-β-induced Smad3/c-Jun Transcriptional Cooperativity* , 2000, The Journal of Biological Chemistry.

[32]  C. Hill,et al.  Transforming Growth Factor β-Independent Shuttling of Smad4 between the Cytoplasm and Nucleus , 2000, Molecular and Cellular Biology.

[33]  Fumiko Itoh,et al.  Signaling of transforming growth factor‐β family members through Smad proteins , 2000 .

[34]  R. Mason,et al.  Inactivation of Smad-Transforming Growth Factor β Signaling by Ca2+-Calmodulin-Dependent Protein Kinase II , 2000, Molecular and Cellular Biology.

[35]  J. Iñiguez-Lluhí,et al.  A Common Motif within the Negative Regulatory Regions of Multiple Factors Inhibits Their Transcriptional Synergy , 2000, Molecular and Cellular Biology.

[36]  A. Dejean,et al.  c-Jun and p53 Activity Is Modulated by SUMO-1 Modification* , 2000, The Journal of Biological Chemistry.

[37]  E. Yeh,et al.  Ubiquitin-like proteins: new wines in new bottles. , 2000, Gene.

[38]  R. Derynck,et al.  Roles of Autocrine TGF-β Receptor and Smad Signaling in Adipocyte Differentiation , 2000, The Journal of cell biology.

[39]  L. Attisano,et al.  Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. M. Mulder,et al.  Role of Ras and Mapks in TGFβ signaling , 2000 .

[41]  T. Shioda,et al.  The Smad4 Activation Domain (SAD) Is a Proline-rich, p300-dependent Transcriptional Activation Domain* , 2000, The Journal of Biological Chemistry.

[42]  H. Moses,et al.  Interdependent SMAD and JNK Signaling in Transforming Growth Factor-β-mediated Transcription* , 1999, The Journal of Biological Chemistry.

[43]  J. Massagué,et al.  Ubiquitin-dependent degradation of TGF-β-activated Smad2 , 1999, Nature Cell Biology.

[44]  G. Blobel,et al.  Cell Cycle–Regulated Attachment of the Ubiquitin-Related Protein Sumo to the Yeast Septins , 1999, The Journal of cell biology.

[45]  Yongsok Kim,et al.  Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Jeffrey L. Wrana,et al.  A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation , 1999, Nature.

[47]  D. Bowtell,et al.  The Cbl protooncoprotein stimulates CSF‐1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation , 1999, The EMBO journal.

[48]  R. Derynck,et al.  Regulation of Smad signalling by protein associations and signalling crosstalk. , 1999, Trends in cell biology.

[49]  Tony Pawson,et al.  Signaling Networks—Do All Roads Lead to the Same Genes? , 1999, Cell.

[50]  E. Nishida,et al.  Identification of Two Smad4 Proteins in Xenopus , 1999, The Journal of Biological Chemistry.

[51]  J. D. Brown,et al.  MEKK-1, a Component of the Stress (Stress-activated Protein Kinase/c-Jun N-terminal Kinase) Pathway, Can Selectively Activate Smad2-mediated Transcriptional Activation in Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[52]  R. Derynck,et al.  Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.

[53]  E. Yeh,et al.  Identification of Three Major Sentrinization Sites in PML* , 1998, The Journal of Biological Chemistry.

[54]  R. van Driel,et al.  Nuclear neighbours: The spatial and functional organization of genes and nuclear domains , 1998, Journal of cellular biochemistry.

[55]  R. Hay,et al.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. , 1998, Molecular cell.

[56]  R. Derynck,et al.  The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. , 1998, Genes & development.

[57]  S. Jentsch,et al.  The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[58]  T. Pawson,et al.  Signaling through scaffold, anchoring, and adaptor proteins. , 1997, Science.

[59]  R. Parekh,et al.  Post-translational modification of proteins and the discovery of new medicine. , 1997, Current opinion in biotechnology.

[60]  Jeffrey L. Wrana,et al.  TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling* , 1997, The Journal of Biological Chemistry.

[61]  K. Miyazono,et al.  Smad6 inhibits signalling by the TGF-β superfamily , 1997, Nature.

[62]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[63]  M. Dasso,et al.  SUMO-1: wrestling with a new ubiquitin-related modifier. , 1997, Trends in biochemical sciences.

[64]  A. Roberts,et al.  Characterization of Functional Domains within Smad4/DPC4* , 1997, The Journal of Biological Chemistry.

[65]  J. Massagué,et al.  The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. , 1997, Genes & development.

[66]  T. Musci,et al.  The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function , 1997, Current Biology.

[67]  L. Mathews,et al.  A Xenopus type I activin receptor mediates mesodermal but not neural specification during embryogenesis. , 1997, Development.

[68]  P. Hoodless,et al.  MADR2 Is a Substrate of the TGFβ Receptor and Its Phosphorylation Is Required for Nuclear Accumulation and Signaling , 1996, Cell.

[69]  J. Massagué,et al.  Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.

[70]  J. Baker,et al.  A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. , 1996, Genes & development.

[71]  J. Graff,et al.  Xenopus Mad Proteins Transduce Distinct Subsets of Signals for the TGFβ Superfamily , 1996, Cell.

[72]  R. Derynck,et al.  Transforming Growth Factor-β (TGF-β)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-β Receptor Complex , 1995, The Journal of Biological Chemistry.

[73]  A. Dejean,et al.  Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix- associated PML bodies , 1995, The Journal of cell biology.

[74]  J. Massagué,et al.  Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin , 1994, Molecular and cellular biology.

[75]  F. Melchior,et al.  SUMO--nonclassical ubiquitin. , 2000, Annual review of cell and developmental biology.

[76]  A. Dejean,et al.  Conjugation with the ubiquitin‐related modifier SUMO‐1 regulates the partitioning of PML within the nucleus , 1998, The EMBO journal.